- Home
- AXSM vs AMG Comparison
AXSM vs AMG Comparison
Compare AXSM & AMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXSM | AMG |
|---|---|---|
| Founded | 2012 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.6B |
| IPO Year | 2015 | 1997 |
Fundamental Metrics
Financial Performance| Metric | AXSM | AMG |
|---|---|---|
| Price | $187.54 | $307.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 21 | 5 |
| Target Price | $190.57 | ★ $335.20 |
| AVG Volume (30 Days) | ★ 876.5K | 383.6K |
| Earning Date | 02-23-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 0.01% |
| EPS Growth | N/A | ★ 6.83 |
| EPS | N/A | ★ 16.71 |
| Revenue | $561,263,000.00 | ★ $2,042,100,000.00 |
| Revenue This Year | $67.43 | $3.63 |
| Revenue Next Year | $58.11 | $13.85 |
| P/E Ratio | ★ N/A | $18.72 |
| Revenue Growth | ★ 65.83 | 1.13 |
| 52 Week Low | $86.99 | $139.22 |
| 52 Week High | $191.50 | $334.00 |
Technical Indicators
Market Signals| Indicator | AXSM | AMG |
|---|---|---|
| Relative Strength Index (RSI) | 67.34 | 53.63 |
| Support Level | $172.05 | $317.10 |
| Resistance Level | $191.50 | $334.00 |
| Average True Range (ATR) | 5.67 | 7.86 |
| MACD | 0.44 | -1.59 |
| Stochastic Oscillator | 83.22 | 17.18 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About AMG Affiliated Managers Group Inc.
Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to mid-size boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of June 2025, AMG's affiliate network—which includes firms like Abacus Capital and Pantheon dedicated to private markets (which accounted for 19% of AUM), AQR Capital and Capula Investment Management in liquid alternatives (24%), and Harding Loevner, Tweedy Browne, Parnassus, and Yacktman in equities, multi-asset, and bond strategies (57%)—had $771 billion in managed assets.